Can Insurers Use Genetic Testing Results? A Reader Wants To Know
Other readers ask what can be done to challenge unexpected medical bills â whether the result of an emergency room visit or after a change in prescription drug coverage.
Drug Costs
501-520 of 704 results
-
-
State Prisons Fail To Offer Cure To 144,000 Inmates With Deadly Hepatitis C
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, canât get the expensive drugs they need to cure it.
-
Podcast: KHNâs âWhat The Health?â Whither Work Requirements?
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Anna Edney of Bloomberg News discuss the latest enrollment numbers for the Affordable Care Act, Medicaid work requirements in Kentucky and President Donald Trumpâs proposed government reorganization plan. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
-
Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk
Itâs getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drugâs high price and insurance company efforts to restrict the use of coupons that shield patients from it.
By Shefali Luthra and Anna Gorman -
Must-Reads Of The Week From Brianna Labuskes
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
-
Must-Reads Of The Week From Brianna Labuskes
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
-
Looking For Lower Medicare Drug Costs? Ask Your Pharmacist For The Cash Price.
Sometimes a drug planâs copayment is higher than the cash price, and under a little-known federal rule, pharmacists have to tell Medicare beneficiaries that â but only if they ask.
By Susan Jaffe -
Benefit Change Could Raise Costs For Patients Getting Drug Copay Assistance
More health plans are refusing to count the copayment assistance offered by drug makers as part of the patientsâ deductibles or out-of-pocket limits.
-
Best Reads Of The Week With Brianna Labuskes
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
-
Pfizer Settles Kickback Case Related To Copay Assistance For $24M
The drugmaker agreed to a settlement with the Justice Department over allegations that it funneled copay assistance money through a foundation to Medicare patients.
-
Watch: Whatâs In The White House Plan To Lower Drug Prices
KHNâs Sarah Jane Tribble explains the key elements of the Trump blueprint on CBS Newsâ "Red & Blue."
-
Drugmakers Blamed For Blocking Generics Have Jacked Up Prices And Cost U.S. Billions
The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.
-
Best Reads Of The Week With Brianna Labuskes
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
-
Vermont Legislators Pass A Drug Importation Law. So What?
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
-
Podcast: KHNâs âWhat The Health?â Much Ado About Drug Prices
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trumpâs proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
-
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trumpâs much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
By Sarah Jane Tribble and Liz Szabo -
Best Reads Of The Week With Brianna Labuskes
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
-
Why Did Novartis Pay Trumpâs Lawyer $1.2 Million? Look At Its Drug Prices
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
By Jay Hancock -
Podcast: KHNâs âWhat The Health?â The Politics Of Rising Premiums And Menu Labeling
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Childrenâs Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.